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DOI: 10.1016/j.ajpath.2011.03.001This Month in AJPHIPK2 May Influence Colon Cancer Survival
Among modulators of the p53 tumor suppressor, HIPK2
may act as a switch governing p53 transition from cyto-
static to pro-apoptotic function. Soubeyran et al (Am J
Pathol 2011, 178:1986–1998) looked for a prognostic
role for HIPK2 in a retrospective series of 80 colon cancer
cases by using a multiplexed cytometric approach on
tissue microarray. Despite a strong impact on p21 tran-
scription, disabling p53 mutations had no prognostic
value, whereas increased expression of HIPK2 protein in
tumor cells, compared to normal cells, had a strong im-
pact on survival. Unexpectedly, this HIPK2 effect did not
appear to be mediated by p53 as it was also observed in
p53-disabling mutated backgrounds. Therefore, high
HIPK2 overexpression correlates with prognosis and may
function independent of p53 in colon cancer survival.
Lipids to the Rescue in Dry Eye Syndrome
The tear-air interface is composed of lipids that prevent
evaporation, and the presence of phospholipid transfer
protein (PLTP) may prevent ocular surface damage and
maintain the anterior lipid layer. Setälä et al (Am J Pathol
2011, 178:2058–2065) induced dry eye conditions in
PLTP-deficient mice and analyzed the resulting ocular
surface. PLTP-deficient mice displayed enhanced cor-
neal epithelial damage, increased corneal permeability to
carboxyfluorescein, and decreased corneal epithelial oc-
cludin expression compared to wild type. Deficiency in
the production of tear PLTP in mice was accompanied by
corneal epithelial damage, similar to human dry eye syn-
drome (DES). When human DES patients were examined,
increased tear fluid PLTP activity was observed. In con-
clusion, PLTP is important for maintaining the delicate
homeostasis between corneal epithelial cells and normal
tear fluid, thus protecting the ocular surface.
Diabetic Skin Is Biomechanically Inferior
Diabetic skin exhibits deficient wound healing properties,
but the reasons are unclear. Bermudez et al (Am J Pathol
2011, 178:2215–2223) hypothesized that diabetic skin pos-
sesses intrinsically inferior biomechanical properties, ren-
dering it more prone to injury. At baseline, both murine and
human diabetic skin was biomechanically inferior com-
pared to nondiabetic skin, with decreased maximum stress
until failure and decreased modulus. Surprisingly, collagen
synthesis genes were significantly up-regulated and colla-
gen degradation genes were significantly down-regulated
in murine diabetic skin. In addition, MMP-2 levels andMMP-9/TIMP-1 ratios, as well as collagen I levels and I:III ratios,
were significantly lower in murine diabetic skin. Thus, the
predisposition of diabetics to wounds may be the result of
impaired tissue integrity at baseline due, in part, to defective
regulation of collagen protein synthesis.
Adipose Injury Cocktail Mitigates Hypoxia
Exudates from injured adipose tissue contain injury-as-
sociated growth factors, which can be replicated as an
adipose injury cocktail (AIC). Eto et al (Am J Pathol 2011,
178:2322–2332) hypothesized that AIC can induce a se-
ries of regenerating and angiogenic processes in the
absence of actual wounding. AIC preferentially activated
adipose-derived stem/progenitor/stromal cells (ASCs) to
proliferate, migrate, and form networks compared with
vascular endothelial cells, whereas vascular endothelial
growth factor did not induce mitogenesis or chemotaxis
in human ASCs. Each AIC component was differently re-
sponsible for activation of ASCs, which differentiated into
adipocytes or vessel-constituting cells rather than other cell
types. In ischemic adipose tissues of mice, AIC administra-
tion enhanced proliferation, especially of CD31/CD34
ASCs, and mitigated tissue hypoxia by increasing capillary
density and reducing fibrogenesis. AIC may thus have ther-
apeutic potential for various ischemic/hypoxic conditions by
inducing adipose remodeling and neovascularization
through activation of ASCs and other cells.
CCN3 Promotes Breast Cancer Bone Metastasis
Bone is a preferred site for breast cancer metastasis,
resulting in pain, fractures, spinal cord compressions,
and hypercalcemia. Ouellet et al (Am J Pathol 2011,
178:2377–2388) identified CCN3 as a novel factor that is
highly expressed in bone metastatic breast cancer cells
from a xenograft mouse model and from patients with
breast cancer. CCN3 overexpression enhanced the abil-
ity of weakly bone metastatic breast cancer cells to col-
onize and grow in the bone without altering their growth in
the mammary fat pad. Further, human recombinant
CCN3 inhibited osteoblast differentiation from primary
bone marrow cultures and impaired osteoblast differen-
tiation. CCN3 promoted osteoclast differentiation from
RANKL-primed monocyte precursors and exerted its pro-
osteoclastogenic effects by promoting calcium oscilla-
tions and NFATc1 nuclear translocation. These data
demonstrate that CCN3 promotes the formation of osteo-
lytic breast cancer metastases by modulating the bone
microenvironment to favor osteoclast differentiation.
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